Marilia Barreca - Search Results

This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Save citations to file

Email citations

Subject: Marilia Barreca - PubMed

To:

From:

Selection:

Format:

MeSH and other data

Add to Collections

Add to My Bibliography

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Results by year

Year	Number of Results
2020	5
2021	2
2022	9
2023	8
2024	2

24 results

Page of 3

Results by year

Page 1

New strategies to hit hematological cancers.

Barreca M, Bertoni F, Barraja P. Barreca M, et al. Eur J Med Chem. 2024 Apr 15;270:116350. doi: 10.1016/j.ejmech.2024.116350. Epub 2024 Mar 20. Eur J Med Chem. 2024. PMID: 38582688 No abstract available.

The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib.

Sartori G, Tarantelli C, Spriano F, Gaudio E, Cascione L, Mascia M, Barreca M, Arribas AJ, Licenziato L, Golino G, Ferragamo A, Pileri S, Damia G, Zucca E, Stathis A, Politz O, Wengner AM, Bertoni F. Sartori G, et al. Among authors: barreca m. Br J Haematol. 2024 Jan;204(1):191-205. doi: 10.1111/bjh.19218. Epub 2023 Nov 27. Br J Haematol. 2024. PMID: 38011941

Advances in developing noncovalent small molecules targeting Keap1.

Barreca M, Qin Y, Cadot MEH, Barraja P, Bach A. Barreca M, et al. Drug Discov Today. 2023 Dec;28(12):103800. doi: 10.1016/j.drudis.2023.103800. Epub 2023 Oct 16. Drug Discov Today. 2023. PMID: 37852355 Free article. Review.

Editorial: Emerging heterocycles as bioactive compounds.

Li Petri G, Holl R, Spanò V, Barreca M, Sardo I, Raimondi MV. Li Petri G, et al. Among authors: barreca m. Front Chem. 2023 Apr 26;11:1202192. doi: 10.3389/fchem.2023.1202192. eCollection 2023. Front Chem. 2023. PMID: 37179776 Free PMC article. No abstract available.

Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel.

Renda M, Barreca M, Borrelli A, Spanò V, Montalbano A, Raimondi MV, Bivacqua R, Musante I, Scudieri P, Guidone D, Buccirossi M, Genovese M, Venturini A, Bandiera T, Barraja P, Galietta LJV. Renda M, et al. Among authors: barreca m. Sci Rep. 2023 May 10;13(1):7604. doi: 10.1038/s41598-023-34440-0. Sci Rep. 2023. PMID: 37165082 Free PMC article.

HSV-1 Glycoprotein D and Its Surface Receptors: Evaluation of Protein-Protein Interaction and Targeting by Triazole-Based Compounds through In Silico Approaches.

Bivacqua R, Romeo I, Barreca M, Barraja P, Alcaro S, Montalbano A. Bivacqua R, et al. Among authors: barreca m. Int J Mol Sci. 2023 Apr 11;24(8):7092. doi: 10.3390/ijms24087092. Int J Mol Sci. 2023. PMID: 37108255 Free PMC article.

Identification of pyrrolo[3',4':3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas.

Barreca M, Spanò V, Rocca R, Bivacqua R, Gualtieri G, Raimondi MV, Gaudio E, Bortolozzi R, Manfreda L, Bai R, Montalbano A, Alcaro S, Hamel E, Bertoni F, Viola G, Barraja P. Barreca M, et al. Eur J Med Chem. 2023 Jun 5;254:115372. doi: 10.1016/j.ejmech.2023.115372. Epub 2023 Apr 12. Eur J Med Chem. 2023. PMID: 37068384

Exploring the anticancer activity and the mechanism of action of pyrrolomycins F obtained by microwave-assisted total synthesis.

Barreca M, Buttacavoli M, Di Cara G, D'Amico C, Peri E, Spanò V, Li Petri G, Barraja P, Raimondi MV, Cancemi P, Montalbano A. Barreca M, et al. Eur J Med Chem. 2023 May 5;253:115339. doi: 10.1016/j.ejmech.2023.115339. Epub 2023 Apr 5. Eur J Med Chem. 2023. PMID: 37054631 Free article.

Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors.

Bivacqua R, Barreca M, Spanò V, Raimondi MV, Romeo I, Alcaro S, Andrei G, Barraja P, Montalbano A. Bivacqua R, et al. Among authors: barreca m. Eur J Med Chem. 2023 Mar 5;249:115136. doi: 10.1016/j.ejmech.2023.115136. Epub 2023 Jan 20. Eur J Med Chem. 2023. PMID: 36708678 Free article. Review.

Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences.

Barreca M, Lang N, Tarantelli C, Spriano F, Barraja P, Bertoni F. Barreca M, et al. Explor Target Antitumor Ther. 2022;3(6):763-794. doi: 10.37349/etat.2022.00112. Epub 2022 Dec 26. Explor Target Antitumor Ther. 2022. PMID: 36654819 Free PMC article. Review.

24 results

Page of 3

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year